AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Eli Lilly CEO and Ryman Hospitality Exec Chairman Make Notable Insider Buys
ByAinvest
Thursday, Aug 14, 2025 1:40 pm ET1min read
Eli Lilly CEO David Ricks purchased 1,632 shares at $644.77 each, totaling $1.05M, while Ryman Hospitality Properties Exec. Chairman Colin Reed bought 8,611 shares at $95.21 each, totaling $819,836. Both purchases were made on Tuesday and Wednesday, respectively, with Eli Lilly trading up 2% and Ryman Hospitality Properties trading off 2.8% on Thursday.
Eli Lilly (LLY) CEO David Ricks purchased 1,632 shares at $644.77 each, totaling $1.05 million, on August 12, 2025 [1]. This move followed a 14% stock decline after the company's oral obesity drug, orforglipron, underperformed in Phase 3 trials. The stock purchase comes with LLY trading at $652.91 per share, down 33% from its 52-week high of $952.73 [1]. Ricks' confidence in the company's long-term strategy signals a vote of confidence in Eli Lilly's GLP-1 therapy expansion [1].Ryman Hospitality Properties (RHP) Executive Chairman Colin Reed bought 8,611 shares at $95.21 each, totaling $819,836, on August 13, 2025 [3]. The $6.1 billion hospitality REIT maintains a GREAT financial health score according to InvestingPro analysis, with a notable 4.85% dividend yield [3]. The purchase increases Reed's direct holdings to 879,017 shares [3].
Both purchases were made on Tuesday and Wednesday, respectively, with Eli Lilly trading up 2% and Ryman Hospitality Properties trading off 2.8% on Thursday.
References:
[1] https://www.tipranks.com/news/eli-lilly-lly-ceo-buys-1-million-of-company-stock-after-recent-crash
[2] https://www.ainvest.com/news/ceo-buy-ins-contrarian-indicator-eli-lilly-ricks-signals-resilience-obesity-drug-markets-2508/
[3] https://www.investing.com/news/insider-trading-news/ryman-hospitality-exec-reed-buys-819k-in-stock-93CH-4189731
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet